A Mouse Study of PEMF and Immunity

Non-ionizing electromagnetic fields and ionizing X-rays differ physically. That distinction does not establish that every non-ionizing exposure is safe or effective: field strength, frequency, duration and anatomy still matter.

What this citation addresses

Díaz-Del Cerro and De la Fuente studied a named low-frequency PEMF system, NEURALTER, in old female CD1 mice exposed for 15 minutes per day over four weeks, and in directly exposed mouse leukocytes. They reported behavioral and immune/redox measures. These results do not test cancer, biofilm clearance, human infection or clinical dosing.

Different questions, not one treatment

Electrical aspects of cell behavior, interactions between microbes and wounds, and neural immune regulation are distinct lines of inquiry. A mouse immune-response experiment cannot show that fields normalize cancer-cell voltage or restore healthy tumor behavior. It also cannot establish treatment for Lyme disease or antibiotic-resistant infection.

Before translating a laboratory effect, investigators need to specify the target and verify exposure at that target. A study would then compare patient-relevant outcomes and adverse effects with appropriate care. Until those steps are completed, this is an example of preclinical immune research, not evidence for cancer or infection therapy.

Evaluating fields in cancer, infection and immune models separately Characterize non-ionizing field exposure

Study a specific cancer, infection, or immune model

Validate each proposed clinical use independently

What the linked references do not establish: The immune-response paper reports findings in old mice, not patient outcomes in cancer or infection.